Human Papillomavirus Regulates HER3 Expression in Head and Neck Cancer: Implications for Targeted HER3 Therapy in HPV+ PatientsToni M. Brand, Jennifer R. Grandis, Daniel E. Johnson et al.|Clinical Cancer Research|2016Cited by 58
Use of nonsteroidal anti-inflammatory drugs predicts improved patient survival for <i>PIK3CA</i>-altered head and neck cancerMatthew L. Hedberg, Jennifer R. Grandis, Noah D. Peyser et al.|The Journal of Experimental Medicine|2019Cited by 57
Cross-talk Signaling between HER3 and HPV16 E6 and E7 Mediates Resistance to PI3K Inhibitors in Head and Neck CancerToni M. Brand, Jennifer R. Grandis, Stefan Hartmann et al.|Cancer Research|2018Cited by 43
Caveolin-1 and Sox-2 are predictive biomarkers of cetuximab response in head and neck cancerMehdi Bouhaddou, Jennifer R. Grandis, Rex H. Lee et al.|JCI Insight|2021Cited by 19
Correction: Cross-talk Signaling between HER3 and HPV16 E6 and E7 Mediates Resistance to PI3K Inhibitors in Head and Neck CancerToni M. Brand, Jennifer R. Grandis, Stefan Hartmann et al.|Cancer Research|2022Cited by 5